Cellectis S.A.
CLLS · NASDAQ
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 19.17M | 10.69M | -89.67M | -106.14M | -2.33 |
| 2023 FY | 755.00K | -6.66M | -97.30M | -101.06M | -1.77 |
| 2024 FY | 41.51M | 32.32M | -59.55M | -36.76M | -0.41 |
| 2025 FY | 72.95M | 63.15M | -33.08M | -67.59M | -0.68 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 261.22M | 135.28M | 89.79M | 75.77M | 117.97M |
| 2023 FY | 334.27M | 249.58M | 136.71M | 85.06M | 84.70M |
| 2024 FY | 383.54M | 252.51M | 143.25M | 91.46M | 131.03M |
| 2025 FY | 324.72M | 248.82M | 63.58M | 119.90M | 75.90M |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | -87.44M | -2.44M | -89.89M | — | -92.42M |
| 2023 FY | -24.75M | -1.07M | -25.82M | — | 43.49M |
| 2024 FY | 22.10M | -2.58M | 19.52M | — | 6.54M |
| 2025 FY | -40.14M | -2.37M | -42.50M | — | -79.67M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 95.66M | 81.64M | — | — | — |
| 2023 FY | 175.60M | 123.95M | — | — | — |
| 2024 FY | 163.02M | 111.23M | — | — | — |
| 2025 FY | 485.35M | 541.67M | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q2 | 16.73M | 14.30M | -9.59M | -23.74M | -0.24 |
| 2025 Q3 | 35.17M | 32.82M | 8.04M | 589.00K | 0.01 |
| 2025 Q4 | 10.40M | 7.40M | -17.35M | -26.32M | -0.27 |
| 2026 Q1 | 5.80M | 1.25M | -27.10M | -17.83M | -0.18 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q2 | 353.97M | 256.86M | 59.81M | 94.77M | 97.11M |
| 2025 Q3 | 343.05M | 242.57M | 52.24M | 92.78M | 100.48M |
| 2025 Q4 | 324.72M | 248.82M | 63.58M | 119.90M | 75.90M |
| 2026 Q1 | 289.19M | 229.27M | 35.00M | 108.60M | 59.92M |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q2 | -10.31M | -305.00K | -10.62M | — | -67.83M |
| 2025 Q3 | -1.57M | -1.18M | -2.75M | — | -7.57M |
| 2025 Q4 | -10.47M | -478.57K | -10.95M | — | 9.29M |
| 2026 Q1 | -15.56M | -265.97K | -15.82M | — | -28.58M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q2 | 153.50M | 188.46M | — | — | — |
| 2025 Q3 | 285.93M | 326.46M | — | — | — |
| 2025 Q4 | 485.59M | 541.90M | — | — | — |
| 2026 Q1 | 318.67M | 392.27M | — | — | — |